About
Kenai Therapeutics is a clinical-stage biotechnology company developing dopamine neuron replacement cell therapies and gene-modified medicines aimed at curing neurological conditions such as Parkinson’s disease.
Explore Kenai Tx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.